On June 9, 2026, the FDA did something it hadn't done since the late 1990s: it added a new active ingredient to the list of permitted sunscreen filters in the United States. The ingredient is bemotrizinol, and if that name means nothing to you, here's the strange part — it has been protecting skin in Europe, Asia, Australia, and Latin America for more than 25 years. Dermatologists have spent two decades asking why Americans couldn't have it. The answer is a story about how the US regulates sunscreen differently from nearly every other country on Earth, and it explains a lot more than one ingredient.
The short answer
The United States regulates sunscreen as an over-the-counter drug, while the European Union regulates it as a cosmetic. That single classification decision meant any new UV filter in America had to clear a drug-approval-style process that, for roughly 25 years, no ingredient managed to survive. Bemotrizinol finally made it through thanks to a streamlined review system Congress created in 2020 — and its approval may open the door for other modern filters the rest of the world already uses.
What is bemotrizinol?
Bemotrizinol — chemists call it bis-ethylhexyloxyphenol methoxyphenyl triazine, and ingredient labels abroad list it as Tinosorb S or Parsol Shield — is a broad-spectrum UV filter that absorbs both UVA and UVB radiation. The FDA's final order permits it in US sunscreens at concentrations up to 6%.
Three properties make it a genuine upgrade rather than just another name on the label:
- It covers UVA well. UVB causes sunburn, but UVA penetrates deeper, drives photoaging, and contributes to skin cancer. Strong UVA filters are exactly where the US ingredient list has been thinnest.
- It is highly photostable. Some chemical filters break down in sunlight — the very thing they're designed to absorb. Bemotrizinol doesn't, so the protection on the label is closer to the protection you actually get over a day outdoors.
- It barely absorbs into the body. The FDA found low levels of absorption through the skin and considers it generally recognized as safe and effective (GRASE) for adults and children 6 months and older.
Sunscreen is a drug in America — and that changed everything
In 1978, the FDA began regulating sunscreens under what's called an OTC monograph — essentially a recipe book of pre-approved active ingredients, doses, and label claims that manufacturers can use without filing individual drug applications. The monograph system froze the US ingredient list in time. The last additions came in the late 1990s, leaving American formulators with 16 permitted UV filters, only a handful of which provide meaningful UVA protection.
Europe took the opposite path. Because the EU classifies sunscreen as a cosmetic, new filters clear a faster safety-review process, and European chemists have had roughly twice as many UV filters to work with — including a generation of modern molecules like bemotrizinol that are more stable, more effective, and more pleasant to wear. That's why the "European sunscreen is better" conversation keeps going viral, and why some Americans have quietly imported their SPF for years.
A timeline of the 25-year logjam
- Late 1990s — The FDA makes its last additions to the US sunscreen ingredient list.
- 2000 — Bemotrizinol (as Tinosorb S) enters the European market.
- 2002 — The FDA creates the Time and Extent Application (TEA) process, meant to fast-track ingredients with long safe-use histories abroad. Eight sunscreen filters eventually enter the queue. None ever gets approved through it.
- 2014 — Congress passes the Sunscreen Innovation Act, forcing the FDA to respond to the backlog. The agency responds — by asking every applicant for more safety data, including studies on absorption and long-term exposure.
- 2019 — The FDA proposes that only two of the 16 US filters, zinc oxide and titanium dioxide, be classified as GRASE outright, and publishes clinical research showing that several common chemical filters absorb into the bloodstream at levels high enough to warrant further study. The agency stresses this doesn't mean those filters are unsafe — only that the old data wasn't enough.
- 2020 — The CARES Act quietly rebuilds the entire OTC monograph system, replacing years-long rulemaking with administrative orders on defined timelines.
- December 12, 2025 — Acting on a request from DSM, bemotrizinol's manufacturer, the FDA issues a proposed order to add the ingredient, with public comments open through January 2026.
- June 9, 2026 — The FDA issues its final order. Bemotrizinol becomes the first new US sunscreen active ingredient in over 20 years, and the first ever approved through the modernized process — final order within seven months of the proposed one.
Why the FDA kept saying "more data"
It's tempting to read this story as pure bureaucratic failure, and members of Congress from both parties have called it that. A Government Accountability Office review found applications sitting in the TEA queue for over a decade. But the FDA's position had a logic to it: sunscreen isn't an occasional-use product. Public health guidance tells hundreds of millions of people to apply it generously, repeatedly, for a lifetime — including to pregnant women and children. The agency wanted modern absorption data before grandfathering in new molecules, and when it ran those studies on the existing US filters, several did show up in the bloodstream at levels above the agency's testing threshold.
Here's the irony: bemotrizinol's large molecular structure means it sits on top of the skin instead of soaking through it — it answers the FDA's absorption concern better than several filters Americans have been using since the 1980s. The molecule the US kept waiting on was, by the agency's own current criteria, one of the cleanest candidates in the queue.
What changes for the sunscreen on your shelf
Not much immediately — and that's worth being honest about. Manufacturers now have to formulate, stability-test, and produce US products containing bemotrizinol, which takes time. Expect the first American formulas in the next year or two.
When they arrive, the practical difference will be most visible in chemical (non-mineral) sunscreens. Until now, avobenzone was the only non-mineral filter in the US with meaningful UVA coverage, and avobenzone degrades in sunlight unless formulators prop it up with stabilizing ingredients. Bemotrizinol holds its protection on its own and can help stabilize the rest of the formula. That means chemical sunscreens that protect longer, feel lighter, and rely less on ingredient workarounds. Mineral sunscreens — zinc oxide and titanium dioxide — remain exactly as effective as they were.
One thing doesn't change: one in five Americans will develop skin cancer by age 70, and the sunscreen that protects you is the one you actually wear and reapply. The best ingredient list in the world doesn't help in the bottle.
Why skin-care professionals are paying attention
For working estheticians, UV protection isn't a side topic — photoaging and sun damage sit underneath half the concerns a client brings to the treatment room, and SPF recommendations are part of nearly every protocol. Ingredient literacy is what separates a professional recommendation from a guess, which is why UV filters, photostability, and skin physiology are part of the core science esthetician students study from day one. Over the next two years, clients are going to walk in asking about "that new European sunscreen ingredient" — and the professionals who can explain it clearly will be the ones clients trust.
The same applies across the industry: anyone studying for a cosmetology, esthetician, or nail license in California is tested on skin science and client protection, and regulatory shifts like this one eventually show up in textbooks, product lines, and treatment menus.
Common questions
Is bemotrizinol safe?
The FDA classifies it as generally recognized as safe and effective for adults and children 6 months and older, based on data including low skin absorption. It also carries 25+ years of real-world use across Europe, Asia, and Australia.
When can I buy sunscreen with bemotrizinol in the US?
The approval took effect June 9, 2026, but products take time to formulate and manufacture. Realistically, expect the first US formulas within a year or two. Keep using your current sunscreen in the meantime — reapplied every two hours, no new ingredient changes that rule.
Does this mean my current sunscreen is bad?
No. The FDA's questions about some older chemical filters concern absorption data, not demonstrated harm, and the agency consistently advises that the risk of skin cancer from unprotected sun exposure far outweighs any known risk from current sunscreens. Mineral sunscreens are unaffected entirely.
Will more new ingredients follow?
Likely, though not instantly. Bemotrizinol proved the modernized pathway works — final order within seven months of the proposed one. Several other modern filters used abroad, including bisoctrizole (Tinosorb M), have long been candidates. Whether their manufacturers file under the new system is now the question to watch.
